NYSE:GL - Globe Life Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $86.20
  • Forecasted Upside: -9.39 %
  • Number of Analysts: 6
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$95.13
▲ +0.69 (0.73%)
1 month | 3 months | 12 months
Get New Globe Life Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GL

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$86.20
▼ -9.39% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Globe Life in the last 3 months. The average price target is $86.20, with a high forecast of $99.00 and a low forecast of $77.00. The average price target represents a -9.39% upside from the last price of $95.13.
Hold
The current consensus among 6 investment analysts is to hold stock in Globe Life. This rating has held steady since October 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
12/8/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 2 sell ratings
3/7/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 2 sell ratings
11/2/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 2 sell ratings
12/2/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/18/2020Morgan StanleyBoost Price TargetUnderweight$86.00 ➝ $92.00Medium
i
10/22/2020JPMorgan Chase & Co.Boost Price TargetOverweight$97.00 ➝ $99.00High
i
10/22/2020Morgan StanleyBoost Price TargetUnderweight$84.00 ➝ $86.00High
i
10/6/2020Morgan StanleyBoost Price TargetUnderweight$82.00 ➝ $84.00Medium
i
8/20/2020Morgan StanleyBoost Price TargetUnderweight$80.00 ➝ $82.00Medium
i
8/12/2020Credit Suisse GroupReiterated RatingBuyLow
i
7/23/2020Credit Suisse GroupReiterated RatingBuyLow
i
7/23/2020Morgan StanleyBoost Price TargetUnderweight$78.00 ➝ $80.00High
i
7/6/2020Morgan StanleyBoost Price TargetUnderweight$72.00 ➝ $78.00High
i
7/2/2020Piper SandlerLower Price TargetNeutral$87.00 ➝ $77.00High
i
6/5/2020Piper SandlerInitiated CoverageNeutral$87.00High
i
4/24/2020SunTrust BanksLower Price TargetHold$108.00 ➝ $79.00Low
i
4/23/2020Morgan StanleyLower Price TargetUnderweight$73.00 ➝ $72.00Medium
i
3/17/2020Morgan StanleyLower Price TargetUnderweight$91.00 ➝ $73.00High
i
1/7/2020BarclaysReiterated RatingSell$84.00Low
i
10/10/2019UBS GroupLower Price TargetSell$85.00 ➝ $84.00Low
i
9/20/2019Credit Suisse GroupInitiated CoverageOutperform$114.00Low
i
(Data available from 12/3/2015 forward)
Globe Life logo
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; and medicare supplement and supplemental health insurance, such as critical illness and accident plans. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Read More

Today's Range

Now: $95.13
$94.11
$95.34

50 Day Range

MA: $88.13
$78.79
$97.52

52 Week Range

Now: $95.13
$56.74
$111.43

Volume

267,907 shs

Average Volume

573,269 shs

Market Capitalization

$9.96 billion

P/E Ratio

14.44

Dividend Yield

0.79%

Beta

1.11